Evidence map›Paper›PMID 42707601›Full record

ReviewFrontiers in oncology2026

KRAS mutations as architects of the tumor immune microenvironment: implications for combination therapies.

Vasudevan Ramachandran, Haily Liduin Koyou, Siddarth Raajasekar, Mohd Hazmi Bin Mohamed, Liyana Najwa Binti Inche Mat, Venkataramanan Swaminathan, Mohd Nazil Salleh, Muhammad Evy Prastiyanto, Nurul Aini Binti Ahmad

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vasudevan RamachandranDepartment of Medical Sciences, Faculty of Health Sciences, MAIWP International University, Taman Batu Muda, Batu Caves, Kuala Lumpur, Malaysia.
Haily Liduin KoyouDepartment of Medical Sciences, Faculty of Health Sciences, MAIWP International University, Taman Batu Muda, Batu Caves, Kuala Lumpur, Malaysia.
Siddarth RaajasekarDepartment of Biotechnology, KIT-Kalaignar Karunanidhi Institute of Technology, Coimbatore, Tamil Nadu, India.
Mohd Hazmi Bin MohamedDepartment of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Liyana Najwa Binti Inche MatDepartment of Neurology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Venkataramanan SwaminathanDepartment of Diagnostic & Allied Health Sciences, Management & Science University, University Drive, Off Persiaran Olahraga, Shah Alam, Selangor, Malaysia.
Mohd Nazil SallehDepartment of Medical Sciences, Faculty of Health Sciences, MAIWP International University, Taman Batu Muda, Batu Caves, Kuala Lumpur, Malaysia.
Muhammad Evy PrastiyantoDepartment of Medical Laboratory Technology, Faculty of Nursing and Health Sciences, Universitas Muhammadiyah Semarang, Semarang, Central Java, Indonesia.
Nurul Aini Binti AhmadDepartment of Medical Sciences, Faculty of Health Sciences, MAIWP International University, Taman Batu Muda, Batu Caves, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oncogenic

Indexed as

immune evasionimmunotherapyKRASPD-L1tumor microenvironment

Identifiers

PMID42707601
PMCPMC13548799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.